Seiwerth S, et al
The FDA placed it in 503A Category 2 ("may present significant safety risks") in 2023, effectively barring compounding pharmacies from using it, then removed it from that category in April 2026 after nominators withdrew their submission, without adding it to the approved Category 1 compounding list
During the waiting period, focus on gentle hydration and barrier support
Chronic Ankle Instability and BPC-157 Chronic ankle instability (CAI) develops in an estimated 20 to 40 percent of individuals following ankle sprain, representing one of the most frustrating long-term consequences of inadequately healed ligament injuries
Blood Flow Support This peptide may help support healthy blood flow to tissues throughout your body
Unlike peptides that target a single receptor or hormone, copper peptide influences gene expression, collagen production, inflammation, and antioxidant defense at the same time